Sherri L. Mizrahy

发表

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.

M. Loh, J. Gastier-Foster, N. Heerema, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Continuous Dose Dasatinib Is Safe and Feasible in Combination with Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Children's Oncology Group (COG) Trial AALL0622

M. Loh, T. Merchant, J. Gastier-Foster, 2012 .